10X Genomics (TXG) PT Lowered to $46 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Tejas Savant lowered the price target on 10X Genomics (NASDAQ: TXG) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
